NHLBI and NIAID announce launch of the REPRIEVE Trial: http://www.nih.gov/news/health/apr2015/nhlbi-15.htm Share Related postsJuly 29, 2024Antiretroviral Abacavir Linked With Cardiovascular Events in REPRIEVE TrialRead moreJuly 29, 2024Exploratory Analysis Associates HIV Drug Abacavir with Elevated Cardiovascular Disease Risk in Large Global TrialRead more